PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 44 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

29 March 2025

  1. (diff | hist) m 02:58 Trifluoroacetate counterion 3,899 +410 LOD_Lorcan (talk | contribs) fix the anchor on an internal link [rollback]

28 March 2025

  1. (diff | hist) 13:54 Grey market 2,605 +29 SupplyWatchSuri (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  2. (diff | hist) 10:27 Lixisenatide 3,215 ±0 ComparisonCato (talk | contribs) expand §Current position [rollback]
  3. (diff | hist) 09:26 Talk:Multi-dose vial 822 +195 StabilityStig (talk | contribs) /* The 28-day rule is being cited as a stability figure */ reply
  4. (diff | hist) 09:15 Xi'an Mokemei Biotechnology 2,368 +38 ChainCustodyChad (talk | contribs) expand §External links [rollback]
  5. (diff | hist) 08:54 WuXi TIDES 10,180 ±0 MassSpecMarv (talk | contribs) split §Operations from §Product range [rollback]
  6. (diff | hist) 06:05 Dipeptidyl peptidase-4 6,022 +259 LCellLeif (talk | contribs) state that the receptor is a class B G-protein-coupled receptor [rollback]
  7. (diff | hist) 04:41 Purity claim inflation 4,595 +872 ForgeryFinder (talk | contribs) expand §Reading against inflation [rollback]
  8. (diff | hist) 04:10 Peptide harm reduction 3,320 ±0 TierTwoTansy (talk | contribs) expand §What documentation can and cannot fix [rollback]
  9. (diff | hist) 03:12 Qingdao Sigma Chemical 10,290 +1,063 CheckSumChase (talk | contribs) add the catalogue size and label it self-reported [rollback]

27 March 2025

  1. (diff | hist) 21:55 Amino acid analysis 3,703 +121 TFA_Counterion (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  2. (diff | hist) 13:52 Talk:Multi-dose vial 611 +390 EndotoxinEd (talk | contribs) /* The 28-day rule is being cited as a stability figure */ reply
  3. (diff | hist) 12:36 Number needed to treat 3,631 ±0 Ref_Desk_Ron (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  4. (diff | hist) 10:18 Talk:Multi-dose vial 400 +302 BUD_Bertram (talk | contribs) /* The 28-day rule is being cited as a stability figure */ new section
  5. (diff | hist) m b 04:20 Underfilling 3,398 +878 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 03:56 Reconstitution calculator 6,007 +731 SchemaSorcha (talk | contribs) add the citation for the stability figures taken from the labelling [rollback]

26 March 2025

  1. (diff | hist) m 23:15 Liquid chromatography-mass spectrometry 3,724 +273 LabRangeLindy (talk | contribs) add the reference standard and its traceability [rollback]
  2. (diff | hist) 22:20 Tirzepatide 6,329 ±0 NNT_Nerys (talk | contribs) rm duplicated pharmacokinetics — the same figures appear in the infobox [rollback]
  3. (diff | hist) 22:12 SURPASS trial programme 3,958 ±0 LeaderLoic (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 21:56 Body composition assessment 4,164 +104 ApoB_Aurelio (talk | contribs) state the fasting requirement explicitly [rollback]
  5. (diff | hist) 21:56 Deamidation 4,219 +22 AnalyticalAnnie (talk | contribs) expand §Detection [rollback]
  6. (diff | hist) 19:27 Satiety signalling 4,441 ±0 ProglucagonPia (talk | contribs) expand §Central integration [rollback]
  7. (diff | hist) 19:18 Certificate of analysis 6,972 ±0 ChainCustodyChad (talk | contribs) correct the description of the sampling procedure [rollback]
  8. (diff | hist) m b 19:13 Dual incretin agonist 4,734 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  9. (diff | hist) m 16:40 Glucose-dependent insulinotropic polypeptide 6,686 ±0 LabelLibby (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]
  10. (diff | hist) m 11:46 Adverse effects of GLP-1 receptor agonists 5,297 +602 SarcopeniaSefa (talk | contribs) expand §Body composition and other effects [rollback]
  11. (diff | hist) 10:05 Talk:Multi-dose vial 959 +227 EndotoxinEd (talk | contribs) /* Merge proposal from Vial — response */ reply
  12. (diff | hist) 08:40 Talk:Peptide content 959 +204 ReportReaderRilla (talk | contribs) /* Which convention does a nominal fill follow? */ reply
  13. (diff | hist) 04:53 HOMA-IR 3,431 ±0 CPeptidePaddy (talk | contribs) add the citation for the imprecision figure [rollback]
  14. (diff | hist) m 03:58 Shanghai Wibson Biotechnology 5,655 +153 EscalationEira (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  15. (diff | hist) m 03:51 High-performance liquid chromatography 6,011 +647 COA_Colwyn (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]

25 March 2025

  1. (diff | hist) 23:36 USP General Chapter 85 4,270 +689 TitrationTheo (talk | contribs) add the repeatability figure with the number of injections [rollback]
  2. (diff | hist) 13:56 Glucagon-like peptide-1 10,239 ±0 GIP_Genoveva (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  3. (diff | hist) m 13:36 Trial data comparison 3,217 +43 CoI_Corin (talk | contribs) add keyboard operation to the control description [rollback]
  4. (diff | hist) 13:23 Orforglipron 4,165 +109 Chromatokid (talk | contribs) expand §Reported clinical findings [rollback]
  5. (diff | hist) 13:21 Talk:Peptide content 748 +234 AnalyticalAnnie (talk | contribs) /* Which convention does a nominal fill follow? */ reply
  6. (diff | hist) 12:41 Talk:Multi-dose vial 748 +290 SyringeSybille (talk | contribs) /* Merge proposal from Vial — response */ reply
  7. (diff | hist) 12:14 SUSTAIN trial programme 4,187 ±0 TimelineTiernan (talk | contribs) expand §Relationship to the obesity programme [rollback]
  8. (diff | hist) m b 11:20 Missed dose 4,407 +284 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  9. (diff | hist) 09:55 Talk:Peptide content 537 +176 UnderfillUna (talk | contribs) /* Which convention does a nominal fill follow? */ new section
  10. (diff | hist) 09:33 Talk:Multi-dose vial 537 +402 StopperingSteff (talk | contribs) /* Merge proposal from Vial — response */ new section
  11. (diff | hist) 07:38 Multi-dose vial 10,398 +2,966 EscalationEira (talk | contribs) add the diluent volume the example assumes [rollback]
  12. (diff | hist) m b 05:27 Methionine oxidation 3,582 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  13. (diff | hist) 03:59 Growth hormone secretagogue 3,576 +143 TesamorelinTeg (talk | contribs) move the vendor-availability paragraph out; that is not article material [rollback]
  14. (diff | hist) 02:54 Glossary of peptide terminology 4,571 +990 BaselineBex (talk | contribs) expand §Analysis and documentation [rollback]
  15. (diff | hist) 01:08 Beta cell function 4,916 ±0 LipidLedgerLou (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]

24 March 2025

  1. (diff | hist) m 15:07 Prior authorisation 3,094 +844 Hedgerow_Hal (talk | contribs) rm the advice on how to obtain coverage [rollback]
  2. (diff | hist) m 13:21 Sterility testing 3,636 +401 SourceHunterSile (talk | contribs) add the repeatability figure with the number of injections [rollback]
  3. (diff | hist) 08:33 Talk:Vial 1,244 +205 MergeMorwenna (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  4. (diff | hist) 06:35 PeptideMeter 3,873 +139 Retention_Time_Rae (talk | contribs) typo [rollback]
  5. (diff | hist) m 02:59 Peptide stability table 3,914 ±0 TalkPageTaro (talk | contribs) add the axis labels to the inline bar figure [rollback]
  6. (diff | hist) m 02:56 Test report forgery 4,138 +123 Retention_Time_Rae (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  7. (diff | hist) 01:46 Peptide 4,933 ±0 CouplingCillian (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  8. (diff | hist) 00:52 Liraglutide 4,532 ±0 SurpassSunniva (talk | contribs) expand §Clinical evidence [rollback]
  9. (diff | hist) 00:45 Lot traceability 4,002 ±0 LurkerLevi (talk | contribs) correct the description of the sampling procedure [rollback]

23 March 2025

  1. (diff | hist) m b 22:50 Retention time 3,306 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) m 15:13 Blind sampling 6,780 ±0 LotTraceLuka (talk | contribs) add the cross-link to the traceability article [rollback]
  3. (diff | hist) m b 06:31 ISO 9001 3,340 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 01:12 Glucagon 5,754 ±0 UnitsUrsula (talk | contribs) state which salt form the mass in the infobox refers to [rollback]

22 March 2025

  1. (diff | hist) m 23:19 C-peptide 3,458 +208 CPeptidePaddy (talk | contribs) expand §Relevance to incretin therapy [rollback]
  2. (diff | hist) m 23:03 Personal importation policy 3,155 +121 StateBoardStace (talk | contribs) attribute the enforcement statement to the published policy [rollback]
  3. (diff | hist) 22:11 Active pharmaceutical ingredient 3,435 +567 ExenatideEzra (talk | contribs) expand §The regulatory frame [rollback]
  4. (diff | hist) 18:49 Intention-to-treat analysis 3,822 +27 ParentCatPansy (talk | contribs) give the absolute risk difference alongside the relative one [rollback]
  5. (diff | hist) m 18:36 Cost per milligram 2,147 +24 StubTagTeodor (talk | contribs) expand §Approved products [rollback]
  6. (diff | hist) m b 17:33 Bachem Holding (Suzhou) 8,987 +94 CiteBot (talk | contribs) bot: add supplier category [rollback]
  7. (diff | hist) 16:12 Peptide supply chain 6,060 ±0 CouplingCillian (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]
  8. (diff | hist) 15:17 Peptide aggregation 4,377 +336 DiluentDiya (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  9. (diff | hist) 09:28 GLP-1 receptor agonist 9,254 ±0 NeutralNikolai (talk | contribs) state which salt form the mass in the infobox refers to [rollback]
  10. (diff | hist) 08:21 Counterfeit peptide 3,878 +535 NAION_Noel (talk | contribs) British spelling per PP:MOS [rollback]
  11. (diff | hist) m 05:25 Insulin syringe unit conversion 3,664 ±0 BetaCellBoyd (talk | contribs) add the assumed syringe scale to the readout label [rollback]
  12. (diff | hist) 04:48 Loss on drying 3,735 ±0 GradientGus (talk | contribs) add the equilibration time to the gradient description [rollback]
  13. (diff | hist) m 00:26 Semaglutide 8,079 ±0 SemaglutideSasha (talk | contribs) expand §Material sold outside licensed supply [rollback]

21 March 2025

  1. (diff | hist) m 23:35 FLOW trial 3,456 +287 SurpassSunniva (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]
  2. (diff | hist) m 22:08 Regulatory status by jurisdiction 3,391 +114 MolarMassMaeve (talk | contribs) add the telehealth prescribing point as attributed [rollback]
  3. (diff | hist) 16:18 Lyophilisation 19,880 +2,238 CostPerMgCory (talk | contribs) expand §Why lyophilised material tolerates ambient shipping [rollback]
  4. (diff | hist) m 10:56 Xi'an Mokemei Biotechnology 2,330 +151 SecondarySrc_Seb (talk | contribs) expand §Product range [rollback]
  5. (diff | hist) m b 09:12 VendorInvestigate 4,188 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]

20 March 2025

  1. (diff | hist) 23:05 Incretin effect 5,768 +343 SatietySunniva (talk | contribs) the glucose-dependence of the insulinotropic effect deserves its own sentence [rollback]
  2. (diff | hist) m b 23:04 CagriSema 3,887 ±0 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 19:15 Enteroendocrine L cell 4,619 ±0 Chromatokid (talk | contribs) expand §Clinical significance [rollback]
  4. (diff | hist) m b 16:40 Prescribing information 3,683 +225 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 11:07 Talk:Vial 1,033 +237 ColdChainCleo (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  6. (diff | hist) m b 09:29 Proglucagon 5,725 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  7. (diff | hist) 08:44 Talk:Insulin syringe unit conversion 959 +73 SigFigSindri (talk | contribs) /* Rounding warning: is it original research? */ reply
  8. (diff | hist) m 08:36 Global access disparity 2,619 ±0 PatientPanelPru (talk | contribs) correct the population figure — the source gives eligible, not treated [rollback]
  9. (diff | hist) 08:22 Talk:Xi'an Mokemei Biotechnology 959 +255 Chromatokid (talk | contribs) /* Extract-derived listings need their own treatment */ reply
  10. (diff | hist) 07:19 Flourishglobal Peptide Biotech 3,588 +747 SecondarySrc_Seb (talk | contribs) expand §Ordering and availability [rollback]
  11. (diff | hist) 05:54 Subcutaneous injection 4,039 ±0 BPC_Bramwell (talk | contribs) the vial strength in the example was inconsistent between two paragraphs [rollback]

19 March 2025

  1. (diff | hist) m 23:22 Repackaging 3,958 ±0 StopperingSteff (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  2. (diff | hist) 22:54 Janoshik Analytical 4,126 ±0 COA_Colwyn (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  3. (diff | hist) m 21:46 Sangon Biotech 6,761 +822 ColdChainCleo (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  4. (diff | hist) 13:05 Talk:Insulin syringe unit conversion 748 +209 Hedgerow_Hal (talk | contribs) /* Rounding warning: is it original research? */ reply
  5. (diff | hist) 12:40 Talk:Xi'an Mokemei Biotechnology 748 +125 ChromCleanupCass (talk | contribs) /* Extract-derived listings need their own treatment */ reply
  6. (diff | hist) m b 11:14 Residual solvent 4,125 +389 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  7. (diff | hist) 10:33 Talk:Insulin syringe unit conversion 537 +265 SigFigSindri (talk | contribs) /* Rounding warning: is it original research? */ new section
  8. (diff | hist) 09:15 Talk:Xi'an Mokemei Biotechnology 537 +298 AnalyticalAnnie (talk | contribs) /* Extract-derived listings need their own treatment */ new section
  9. (diff | hist) 09:14 Talk:Vial 822 +257 EndotoxinEd (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  10. (diff | hist) N 09:00 Xi'an Mokemei Biotechnology 2,179 +2,179 COA_Colwyn (talk | contribs) start organisation article — registry facts and product scope only

18 March 2025

  1. (diff | hist) 21:22 Nantong Guangyuan Chemical 9,606 +617 HarmReductionHen (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  2. (diff | hist) 15:22 Talk:Shanghai Wibson Biotechnology 1,244 +231 DeletionDeb (talk | contribs) /* Notability: what a five-year registry history establishes */ reply